Large-scale production of
therapeutic vesicles from cells
using direct extrusion method
Exosomes are nanosized vesicles naturally released
from various types of cells, including immune cells
and stem cells. Exosomes have garnered broad attention as a next-generation drug delivery system with their roles
in various intercellular communications.
However, a minuscule quantity of exosomes has been a drawback for commercialization.
MDimune Inc. developed the BioDrone® Technology for producing cell-derived vesicles (CDVs, exosome mimetics) in a large quantity from various cell sources by extrusion method. MDimune Inc. is currently optimizing this innovative platform technology to tackle various human diseases.